These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34047914)

  • 1. A National Cost Analysis of Community Interventions to Prevent Underage Drinking and Prescription Drug Misuse.
    Close C; Elek E; Roberts CA; Dunlap LJ; Graham PW; Scaglione NM; Palen LA; Clarke T
    Prev Sci; 2021 Nov; 22(8):1071-1085. PubMed ID: 34047914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Latent Class Analysis of Prevention Approaches Used to Reduce Community-Level Prescription Drug Misuse in Adolescents and Young Adults.
    Scaglione NM; Buben A; Williams J; Cance JD; Elek E; Clarke T; Graham PW
    J Prim Prev; 2021 Jun; 42(3):279-296. PubMed ID: 33811569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quasi-experimental evaluation of partnerships for success's impact on community-level ethanol and prescription drug poisoning rates.
    Morgan-Lopez AA; Elek E; Graham PW; Saavedra LM; Bradshaw M; Clarke T
    Addict Behav; 2019 Aug; 95():220-225. PubMed ID: 30981034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of alcohol misuse among children, youths and young adults.
    Korczak D; Steinhauser G; Dietl M
    GMS Health Technol Assess; 2011; 7():Doc04. PubMed ID: 21808659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intervention Costs From Communities Putting Prevention to Work.
    Honeycutt AA; Khavjou OA; Bradley C; Neuwahl S; Hoerger TJ; Bellard D; Cash AJ
    Prev Chronic Dis; 2016 Jul; 13():E98. PubMed ID: 27468157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An innovative collaboration between a school of pharmacy and community-based organization for substance misuse prevention education.
    Lyons-Burney H; Godby J
    J Am Pharm Assoc (2003); 2023; 63(1):356-360. PubMed ID: 36372641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Scottish national LifeCurve™ survey: costs of functional decline, opportunities to achieve early intervention to support well-being in later life, and meaningfulness of the LifeCurve™.
    Kelso S; Mitchell S; Rowe PJ; Gore P
    Public Health; 2020 Mar; 180():129-135. PubMed ID: 31887609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing Binge Drinking in Adolescents through Implementation of the Strategic Prevention Framework.
    Anderson-Carpenter KD; Watson-Thompson J; Chaney L; Jones M
    Am J Community Psychol; 2016 Mar; 57(1-2):36-46. PubMed ID: 27217310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of community-based interventions from the Community Transformation Grants.
    Khavjou OA; Honeycutt AA; Yarnoff B; Bradley C; Soler R; Orenstein D
    Prev Med; 2018 Jul; 112():138-144. PubMed ID: 29678616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisite cost analysis of a school-based voluntary alcohol and drug prevention program.
    Kilmer B; Burgdorf JR; D'Amico EJ; Miles J; Tucker J
    J Stud Alcohol Drugs; 2011 Sep; 72(5):823-32. PubMed ID: 21906509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the feasibility of implementing a prescription drug misuse prevention intervention in the community: a mixed methods study.
    Al Rawwad T; Tata V; Wanat MA; Campbell D; Thornton D
    BMC Public Health; 2023 Apr; 23(1):728. PubMed ID: 37085838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Community Coalition Capacity and its Association with Underage Drinking Prevention Effectiveness in the Context of the SPF SIG.
    Flewelling RL; Hanley SM
    Prev Sci; 2016 Oct; 17(7):830-40. PubMed ID: 27392783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
    Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
    J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. School and work status, drug-free workplace protections, and prescription drug misuse among Americans ages 15-25.
    Miller T; Novak SP; Galvin DM; Spicer RS; Cluff L; Kasat S
    J Stud Alcohol Drugs; 2015 Mar; 76(2):195-203. PubMed ID: 25785794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Strategic Prevention Framework State Incentives Grant (SPF SIG) on state prevention infrastructure in 26 states.
    Orwin RG; Stein-Seroussi A; Edwards JM; Landy AL; Flewelling RL
    J Prim Prev; 2014 Jun; 35(3):163-80. PubMed ID: 24619188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of seven behavioural interventions to prevent drug misuse in vulnerable populations.
    Pennington B; Collins B; Leigh S; Martin AP; Owen L; Fischer A; Sumnall H; Bates G
    Int J Drug Policy; 2018 Jul; 57():42-50. PubMed ID: 29679810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underage Drinking: A Review of Trends and Prevention Strategies.
    Harding FM; Hingson RW; Klitzner M; Mosher JF; Brown J; Vincent RM; Dahl E; Cannon CL
    Am J Prev Med; 2016 Oct; 51(4 Suppl 2):S148-57. PubMed ID: 27476384
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.